The site will be in the Beijing Economic and Technological Development Zone where Sanofi already has production facilities ...

Eli Lilly and Company has invested over US $700 million to enhance its global insulin manufacturing facilities in China, France, Lilly headquarters in Indianapolis, USA, and Puerto Rico.

Understanding the molecular mechanisms of insulin resistance remains a major medical challenge of the twenty-first century. Over the last half-century, many hypotheses have been proposed to ...

Scientists have developed a once-a-day nasal gel formulation for the delivery of insulin that could put an end to injections for Type 1 diabetes sufferers. In results published today in the Royal ...

Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, ...

Amazon Pharmacy said it will now automatically apply manufacturer-sponsored coupons on more than 15 of the most prescribed insulin and diabetes care brand-name products to eligible customers for a ...